J. H. Chesebro

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

J. H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · 1987 · 735 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +14

Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs.

Jules Y.T. Lam, J. H. Chesebro, Peter M. Steele et al. · Circulation · 1991 · 58 citations

Persistent thrombin generation in humans during specific thrombin inhibition with hirudin.

Pierre Zoldhelyi, J. Bichler, Whyte G. Owen et al. · Circulation · 1994 · 57 citations · Full text

Antithrombotic therapy and progression of coronary artery disease. Antiplatelet versus antithrombins.

J. H. Chesebro, Mark Webster, Pierre Zoldhelyi et al. · PubMed · 1992 · 48 citations

Antithrombotic Therapy, Specific Thrombin Inhibition, Coronary Artery Disease +17